104 related articles for article (PubMed ID: 22094528)
1. Confusion between gamma-linolenic acid and gamma-linoleic acid.
Sriram K
Crit Care Med; 2011 Dec; 39(12):2789; author reply 2789-90. PubMed ID: 22094528
[No Abstract] [Full Text] [Related]
2. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury.
Stapleton RD; Martin TR; Weiss NS; Crowley JJ; Gundel SJ; Nathens AB; Akhtar SR; Ruzinski JT; Caldwell E; Curtis JR; Heyland DK; Watkins TR; Parsons PE; Martin JM; Wurfel MM; Hallstrand TS; Sims KA; Neff MJ
Crit Care Med; 2011 Jul; 39(7):1655-62. PubMed ID: 21423000
[TBL] [Abstract][Full Text] [Related]
3. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury.
Rice TW; Wheeler AP; Thompson BT; deBoisblanc BP; Steingrub J; Rock P;
JAMA; 2011 Oct; 306(14):1574-81. PubMed ID: 21976613
[TBL] [Abstract][Full Text] [Related]
4. Supplementation in acute lung injury.
König K; Rosenberger P; Mirakaj V
JAMA; 2012 Jan; 307(2):145; author reply 145-6. PubMed ID: 22235080
[No Abstract] [Full Text] [Related]
5. Supplementation in acute lung injury.
Bistrian BR
JAMA; 2012 Jan; 307(2):144-5; author reply 145-6. PubMed ID: 22235079
[No Abstract] [Full Text] [Related]
6. Supplementation in acute lung injury.
Felbinger TW; Weigand MA; Mayer K
JAMA; 2012 Jan; 307(2):144; author reply 145-6. PubMed ID: 22235078
[No Abstract] [Full Text] [Related]
7. Pharmaconutrition in acute lung injury.
Cook DJ; Heyland DK
JAMA; 2011 Oct; 306(14):1599-600. PubMed ID: 21976612
[No Abstract] [Full Text] [Related]
8. Fish oil is not the fix for acute lung injury.
Wiedemann HP
Crit Care Med; 2011 Jul; 39(7):1829-30. PubMed ID: 21685749
[No Abstract] [Full Text] [Related]
9. ω-3 fatty acids, γ-linolenic acid, and antioxidants: immunomodulators or inert dietary supplements?
Schott CK; Huang DT
Crit Care; 2012 Nov; 16(6):325. PubMed ID: 23176247
[TBL] [Abstract][Full Text] [Related]
10. Nutritional immunomodulation in critically ill children with acute lung injury: feasibility and impact on circulating biomarkers.
Jacobs BR; Nadkarni V; Goldstein B; Checchia P; Ayad O; Bean J; DeMichele S;
Pediatr Crit Care Med; 2013 Jan; 14(1):e45-56. PubMed ID: 23295853
[TBL] [Abstract][Full Text] [Related]
11. Lipids in critical care medicine.
Ott J; Hiesgen C; Mayer K
Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):267-73. PubMed ID: 21546231
[TBL] [Abstract][Full Text] [Related]
12. Effect of dietary supplementation with omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double-blind, controlled trial.
Jung JY; Kwon HH; Hong JS; Yoon JY; Park MS; Jang MY; Suh DH
Acta Derm Venereol; 2014 Sep; 94(5):521-5. PubMed ID: 24553997
[TBL] [Abstract][Full Text] [Related]
13. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the outcome of mechanically ventilated, critically ill, septic patients.
Grau-Carmona T; Morán-García V; García-de-Lorenzo A; Heras-de-la-Calle G; Quesada-Bellver B; López-Martínez J; González-Fernández C; Montejo-González JC; Blesa-Malpica A; Albert-Bonamusa I; Bonet-Saris A; Herrero-Meseguer JI; Mesejo A; Acosta J
Clin Nutr; 2011 Oct; 30(5):578-84. PubMed ID: 21474219
[TBL] [Abstract][Full Text] [Related]
14. Influence of an eicosapentaenoic and docosahexaenoic acid-enriched enteral nutrition formula on plasma fatty acid composition and biomarkers of insulin resistance in the elderly.
Olza J; Mesa MD; Aguilera CM; Moreno-Torres R; Jiménez A; Pérez de la Cruz A; Gil A
Clin Nutr; 2010 Feb; 29(1):31-7. PubMed ID: 19573960
[TBL] [Abstract][Full Text] [Related]
15. Acute lung injury and nutritional support.
Gasperino J; Kvetan V
Crit Care Med; 2006 Apr; 34(4):1265-7. PubMed ID: 16550085
[No Abstract] [Full Text] [Related]
16. Re: The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data.
Ferrie S
JPEN J Parenter Enteral Nutr; 2010; 34(4):452; author reply 453-4. PubMed ID: 20631393
[No Abstract] [Full Text] [Related]
17. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
De Vizia B; Raia V; Spano C; Pavlidis C; Coruzzo A; Alessio M
JPEN J Parenter Enteral Nutr; 2003; 27(1):52-7. PubMed ID: 12549599
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 5-lipoxygenase induces cell death in anti-inflammatory fatty acid-treated HL-60 cells.
Gillis RC; Daley BJ; Enderson BL; Karlstad MD
JPEN J Parenter Enteral Nutr; 2004; 28(5):308-14. PubMed ID: 15449569
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
Olveira G; Olveira C; Acosta E; Espíldora F; Garrido-Sánchez L; García-Escobar E; Rojo-Martínez G; Gonzalo M; Soriguer F
Arch Bronconeumol; 2010 Feb; 46(2):70-7. PubMed ID: 20045240
[TBL] [Abstract][Full Text] [Related]
20. Nutrition therapy for acute respiratory distress syndrome.
Preiser JC
JPEN J Parenter Enteral Nutr; 2008; 32(6):669-70. PubMed ID: 18974251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
